Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M1,394Revenue (TTM) $M281Net Margin (%)-23.4Altman Z-Score2.4
Enterprise Value $M1,281EPS (TTM) $-1.7Operating Margin %-18.9Piotroski F-Score3
P/E(ttm)--Beneish M-Score-3.3Pre-tax Margin (%)-23.3Higher ROA y-yN
Price/Book5.310-y EBITDA Growth Rate %--Quick Ratio7.3Cash flow > EarningsY
Price/Sales4.75-y EBITDA Growth Rate %--Current Ratio7.8Lower Leverage y-yN
Price/Free Cash Flow84.5y-y EBITDA Growth Rate %-749.4ROA % (ttm)-13.8Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-27.6Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M40.3ROIC % (ttm)-33.7Gross Margin Increase y-yN

Gurus Latest Trades with PCRX

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

PCRX is held by these investors:



PCRX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
HASTINGS PAUL JDirector 2017-08-22Sell1,044$36.15-4.43view
Williams Kristen MarieCAO and General Counsel 2017-08-15Sell3,461$36.75-5.99view
STACK DAVID MCEO and Chairman 2017-08-15Sell28,885$36.37-5view
Froimson MarkDirector 2017-08-08Buy100$37.13-6.95view
Riker Lauren BullaroVice President, Finance 2017-06-07Sell1,119$44.37-22.13view
STACK DAVID MCEO and Chairman 2017-06-05Sell4,311$43.32-20.24view
Scibetta James SPresident 2017-06-05Sell1,966$43.32-20.24view
Riker Lauren BullaroVice President, Finance 2017-06-05Sell601$43.32-20.24view
Jones James BSVP & Chief Medical Officer 2017-06-05Sell767$43.32-20.24view
Braunstein ScottSVP, Strategy & Corp. Dev. 2017-06-05Sell768$43.32-20.24view

Press Releases about PCRX :

Quarterly/Annual Reports about PCRX:

News about PCRX:

Articles On GuruFocus.com
Steven Cohen Doubles Down on Sickle Cell Disease Therapeutics Company Global Blood Oct 04 2017 
Pacira Pharmaceuticals CEO to Testify at White House Opioid Crisis Commission Meeting Sep 27 2017 
New Research: Overprescribing of Postsurgical Opioids Poses a Serious Threat to Patients and their C Sep 26 2017 
Pacira Pharmaceuticals to Present at the 2017 Cantor Fitzgerald Global Healthcare Conference Sep 20 2017 
Steven Cohen Dives Into Array BioPharma Sep 13 2017 
Pacira Pharmaceuticals, Aetna, and the American Association of Oral and Maxillofacial Surgeons Join Sep 13 2017 
Pacira Pharmaceuticals Announces Multiple EXPAREL Data Presentations at the Upcoming New York School Sep 06 2017 
Pacira Pharmaceuticals to Present at the 2017 H.C. Wainwright 19th Annual Global Investment Conferen Sep 05 2017 
Pacira Pharmaceuticals to Present at the 2017 Wells Fargo Healthcare Conference Aug 31 2017 
Steven Cohen Plunges Into Opioid Replacement Maker Pacira Pharmaceuticals Aug 24 2017 
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}
FEEDBACK